ストックスクリーナーアプリを入手
1.25
1.64%
0.03
Pacific Biosciences Of California Inc (PACB) 最新ニュース
PacBio (PACB) Launches New Sequencing Technology for Global Dist - GuruFocus
PacBio ships new sequencing chemistry, cuts genome cost - Investing.com
AI-tuned PacBio upgrade brings sub-$300 human genomes at scale - Stock Titan
Pacific Biosciences: Pressure Is Rising (NASDAQ:PACB) - Seeking Alpha
PACB (Pacific Biosciences of California) ROC % : -47.66% (As of Mar. 2026) - GuruFocus
Q4 2025 Pacific Biosciences of California Inc Earnings Call Transcript - GuruFocus
PACB Stock Price, Quote & Chart | PACIFIC BIOSCIENCES OF CALIF (NASDAQ:PACB) - ChartMill
PacBio to Participate in the Jefferies Global Healthcare Conference - Yahoo Finance
Here's why you should add PacBio stock to your portfolio now - MSN
Pacific Biosciences of California (PACB) Stock Price, News & Analysis - MarketBeat
Pacific Biosciences of California sets $300 price point for 20x human genome sequencing on Revio - Traders Union
PACB & Blank Bio Partner to Advance RNA Foundation Models in Oncology - Yahoo Finance
PACB Secures $7.2M in Seed Funding and Partners with Blank Bio - GuruFocus
PacBio wins Basecamp Research deal for Trillion Gene Atlas initiative - MSN
Blank Bio Announces Seed Financing and Strategic Collaboration with PacBio to Advance RNA Foundation Models for Precision Oncology - BioSpace
AI lab Blank Bio raises $7.2M, teams with PacBio on tumor RNA - Stock Titan
PacBio tumbles after narrowing full-year revenue guidance - MSN
Sequencing constraints lifted as Pacific Biosciences of California enables combined genetic and methylation detection - Traders Union
PacBio expects $165M-$175M 2026 revenue as SPRQ-Nx ships later this month - MSN
Pacific Biosciences of California introduces HiFi Starter Kit to expand long-read sequencing access - Traders Union
Pacific Biosciences stock (US6932471010): Latest developments and market position - AD HOC NEWS
PACB SEC FilingsPacific Biosc 10-K, 10-Q, 8-K Forms - Stock Titan
PACB Technical Analysis | Trend, Signals & Chart Patterns | PACIFIC BIOSCIENCES OF CALIF (NASDAQ:PACB) - ChartMill
PacBio (PACB) Q1 earnings report preview: What to look for - MSN
Pacific Biosciences (PACB) Reports Q1 EPS - Insider Monkey
Pacific Biosciences of California brings global researchers together in Fukuoka - Traders Union
Why PacBio (PACB) Shares Are Getting Obliterated Today - Yahoo Finance
5 Best Penny Stocks to Buy Before They Explode - Insider Monkey
PACB Q1 Deep Dive: Consumables Growth and Clinical Adoption Offset Instrument Weakness - Yahoo Finance
Pacific Biosciences of California launches PacBioPRISM tour finale in Japan to drive HiFi innovation - Traders Union
Pacific Biosciences of California, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:PACB) 2026-05-11 - Seeking Alpha
PACB Maintained by Barclays -- Price Target Raised to $1.50 - GuruFocus
TradingKey - TradingKey
Long-read genome scan spots key variants in unexplained subfertility - Stock Titan
PacBio (PACB) Q1 2026 Earnings Call Transcript - AOL.com
Pacific Biosciences Of California (PACB) Q4 Loss Highlights Ongoing Break From Bullish Profitability Narratives - Sahm
Pacific Biosciences of California, Inc. Q1 2026 Financial Results and SEC 10-Q Filing Highlights - Minichart
[10-Q] PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Quarterly Earnings Report - Stock Titan
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 1Q 2026: Revenue $37.18M, EPS ($0.03) — 10-Q Summary - TradingView
Pacific Biosciences stock (US6932471010): Flat Q1 revenue amid funding pressure in U.S. research sec - AD HOC NEWS
Pacific Biosciences (PACB) Shares Drop Following Q1 Revenue Miss - GuruFocus
Pacific Biosciences Shares Fall Amid 1Q Revenue Pressures - Moomoo
Pacific Biosciences of California, Inc. (PACB) Stock Rises on Q1 2026 Earnings - Moomoo
PACB Q1 Earnings Beat, Revenues Miss Estimates, Gross Margin Down - TradingView
0.32%
0.17%
大文字化:
|
ボリューム (24 時間):